Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) — The "Global Market for Artificial Intelligence in Healthcare 2023" report has been added to ResearchAndMarkets.com's offering.
As of 2021, the market is estimated to be valued at approximately USD 6.1 billion, with a projected Compound Annual Growth Rate (CAGR) of around 44.9% from 2021 to 2026.
The analysts brings you the latest research on this highly lucrative industry. The Global Market for Artificial Intelligence in Healthcare 2023 offers an in-depth analysis of the dynamic landscape of AI in the healthcare sector.
Over the years, the integration of artificial intelligence has revolutionized healthcare, impacting diagnostics, treatment planning, and patient care. This comprehensive report delves into key components, technological foundations, and applications of AI in healthcare, while also providing strategic insights through SWOT and Porter's Five Forces analyses.
The global market for Artificial Intelligence (AI) in healthcare has witnessed remarkable growth in recent years, fundamentally transforming the landscape of healthcare delivery. AI, characterized by its capacity to mimic human cognitive functions, has found extensive applications in diagnostics, predictive analytics, personalized treatment plans, and more.
One of the key drivers propelling this growth is the escalating demand for advanced healthcare solutions. The integration of AI technologies enhances clinical decision-making processes, optimizes healthcare workflows, and ultimately leads to improved patient outcomes. The proliferation of healthcare data, coupled with the rising awareness of AI's potential in healthcare, has further fueled this trend.
The market can be dissected into various segments based on components, technologies, applications, and geographical regions. In terms of components, the market encompasses software solutions, hardware, and services, including consulting, integration, and maintenance. Meanwhile, AI technologies employed in healthcare include machine learning, natural language processing (NLP), deep learning, and other specialized areas like computer vision.
Applications of AI in healthcare are diverse and impactful. Medical imaging and diagnostics have been revolutionized by AI algorithms that enhance the accuracy and speed of image interpretation. In drug discovery and development, AI is streamlining the process, potentially accelerating the arrival of new therapies to the market. Personalized medicine and treatment planning are benefiting from AI's ability to analyze individual patient data and tailor interventions accordingly.
Overall, the report caters to a diverse audience interested in gaining in-depth insights into the global market for Artificial Intelligence in Healthcare in 2023, making it a valuable resource for informed decision-making and strategic planning.
DeepMind Technologies Limited
Nuance Communications, Inc.
Key Topics Covered:
A. Executive Summary
B. Market Overview
B.1 Industry Definition
B.2 Market Overview (2017-2021)
B.3 Impact of COVID-19 Pandemic on AI in Healthcare Market
C. Evolution of AI in Healthcare
C.1 Current Landscape and Trends (2017-2021)
C.2 Market Dynamics
C.3 Industry Drivers
C.4 Industry Opportunities
C.5 Industry Challenges
D. Global Market for Artificial Intelligence in Healthcare: SWOT Analysis
D.1 Strengths to Exploit
D.2 Weaknesses to Overcome
D.3 Opportunities to Explore
D.4 Threats to Overcome
D.5 Summary of SWOT Analysis Findings
E. Global Market for Artificial Intelligence in Healthcare: Porter's Five Forces Strategy Analysis
E.2 Bargaining Power of Buyers
E.3 Bargaining Power of Suppliers
E.4 Competitive Rivalry in the Industry
E.5 Threat of New Entrants
E.6 Threat of Substitutes
F. AI in Healthcare: Technological Foundations
F.1 Machine Learning and Deep Learning
F.2 Natural Language Processing (NLP)
F.3 Computer Vision
F.4 Context Aware Processing
F.5 Robotics and Automation
G. Applications of AI in Healthcare
G.1 Medical Imaging and Diagnostics
G.2 Drug Discovery and Development
G.3 Personalized Medicine and Treatment Planning
G.4 Virtual Health Assistants and Chatbots
G.5 Predictive Analytics for Patient Outcomes
G.6 Clinical Trials and Research
H. Market Segmentation by Component
H.1 Software Solutions
I. Market Segmentation by Technology
I.1 Natural Language Processing (NLP)
I.2 Machine Learning
I.3 Deep Learning
I.4 Others (e.g., Robotics, Computer Vision)
J. Market Segmentation by Application
J.1 Hospitals and Healthcare Providers
J.2 Pharmaceutical Companies and Research Labs
J.3 Healthcare Payers and Insurers
K. Regional Analysis
K.1 North America
K.4 Latin America
K.5 Middle East and Africa
L. Regulatory Landscape
L.1 FDA and Other Regulatory Bodies
L.2 Compliance and Standards
M. Global Market for AI in Healthcare: Investment and Funding Analysis
M.1 Venture Capital Investments
M.2 Public and Private Funding Initiatives
M.3 Conclusion and Recommendations
M.4 Major Deals (Mergers & Acquisitions)
N. Competitive Analysis
N.1 Market Share Analysis
N.2 Strategic Initiatives
N.4 Major Industry Players
N.4.1 Company Profile
N.4.2 Major Products and Projects
N.4.3 Strategic Initiatives
N.4.4 SWOT Analysis
N. Case Studies and Real-world Cases
O. Challenges and Market Outlook (2022-2027)
O.1 Ethical and Privacy Concerns
O.2 Security and Data Protection
O.3 Integration Challenges
O.4 Future Trends and Developments
P. Glossary of Terms
For more information about this report visit https://www.researchandmarkets.com/r/1clal
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Warren Buffett is known for holding onto his S&P 500 stocks forever. But that definitely wasn't the case recently.
Berkshire Hathaway's record $157 billion cash pile is a warning sign for investors, Portfolio Wealth Advisors' Lee Munson said.
Brewer looks to win back its core buyers.
Gary Shilling, a veteran economist and money manager who called the mid-2000s housing crash, says he's betting against stocks and commodities.
(Bloomberg) — Jim Chanos, the legendary short seller known for his bearish bets against Enron and Tesla Inc., is shuttering his hedge funds after almost four decades.Most Read from BloombergAston Martin Owner Lawrence Stroll Sells F1 Team Stake at £1 Billion ValuationBacklash Spreads Over Musk’s Endorsement of Antisemitic PostOpenAI Ousts Altman as CEO; Board Says It Lost Confidence in HimHamas Mastermind Who Tricked Israel Is Top Target in Gaza TunnelsApple Plans to Make It Easier to Text Betw
Warren Buffett, the venerated investor and CEO of Berkshire Hathaway, is set to amass over $6 billion in dividend income in the coming year, with a significant portion of this windfall emanating from just three stocks. This substantial income stream underscores the effectiveness of Buffett's investment strategy, one that favors profitability and long-term value. Top Dividend Earners in Buffett’s Portfolio Buffett’s predilection for dividend-bearing stocks isn’t just a matter of preference; it’s
As expensive as mega-cap tech stocks are, they are still worth holding onto since they are at the center of the AI tech transformation that is just beginning, writes an Evercore analyst. Many smaller tech companies won’t be able to compete with larger firms, which are using their ample profits to invest heavily in AI. Salesforce and Intuit are two companies that aren’t that expensive and are likely to post strong growth.
Another robust quarter from NVIDIA appears to be in the cards, with scorching-hot Data Center demand and improving Gaming revenues likely to provide tailwinds. How will shares react?
A new report claims that Apple has again paused advertising on social media powerhouse X, in protest of owner Elon Musk's promotion of, and Apple's advertising adjacent to, antisemitic content.
NIO Inc. (NIO) closed at $7.39 in the latest trading session, marking a -0.14% move from the prior day.
Amazon will begin selling Hyundai vehicles online in the U.S. starting next year, the two companies said on Thursday. Customers will be able to shop for, equip and buy a car at Amazon.com and schedule delivery through a local Hyundai dealer, the companies said. The agreement is an expansion of a deal announced two years ago to expand Hyundai's digital showroom on Amazon.com, enabling customers to configure a vehicle, calculate the price and locate a dealer to complete the sale.
Two companies behind the supplements brand Balance of Nature had flouted years of warnings, the FDA said.
The executive churn at beleaguered Nikola Corp. continued with the resignation of CFO Stasy Pasterick after just six months. The post Nikola CFO resigns after 6 months in role appeared first on FreightWaves.
(Bloomberg) — OpenAI, the pioneer of widely used tools that generate specialized digital content from simple prompts, ousted its co-founder and Chief Executive Officer Sam Altman and lost another senior executive after a series of escalating disagreements over fundamental questions at the heart of artificial intelligence: How to keep the technology safe while also making money from it.Most Read from BloombergAston Martin Owner Lawrence Stroll Sells F1 Team Stake at £1 Billion ValuationBacklash
Warren Buffett is the fifth-richest man in the world, according to the Forbes Real Time Billionaires Index, and one the most successful investors of this age. His company, Berkshire Hathaway Inc., reported a 40% rise in operating earnings in the third quarter. Berkshire Hathaway also reported a record $157.2 billion cash holding as of Sept. 30. The majority of Buffett's earnings came from his insurance business, with Geico reporting total underwriting earnings of over $1 billion in the last quar
The FT reported Friday that Saudi Arabia is considering prolonging production cuts into 2024, sending international and US oil prices higher.
Nvidia, a giant in data centers and gaming, is supercharging investor interest in artificial intelligence. Is Nvidia stock a buy after breaking out, with earnings due next week? On Nov. 13, Nvidia unveiled the highly anticipated H200, its latest graphics processing unit for training AI (artificial intelligence) models.
Beam Therapeutics Inc. (BEAM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
RESEARCH REPORTS These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or recommendations of Barron’s.
Fund flow data show investor skepticism is high as retail investors ditched stocks in October at the fastest pace since 2021.